BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6475544)

  • 1. Effects of synthetic porcine GIP on the PP release in healthy subjects.
    Jorde R; Burhol PG
    Acta Physiol Scand; 1984 Jun; 121(2):143-6. PubMed ID: 6475544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of atropine on GIP-induced insulin and pancreatic polypeptide release in man.
    Amland PF; Jorde R; Burhol PG; Giercksky KE
    Scand J Gastroenterol; 1985 Apr; 20(3):321-4. PubMed ID: 3890140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What are 'physiological' plasma GIP levels in man after intravenous infusion of porcine GIP?
    Jorde R; Amland PF; Burhol PG; Giercksky KE
    Scand J Gastroenterol; 1985 Apr; 20(3):268-71. PubMed ID: 4001836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intravenously infused porcine GIP on serum insulin, plasma C-peptide, and pancreatic polypeptide in non-insulin-dependent diabetes in the fasting state.
    Amland PF; Jorde R; Aanderud S; Burhol PG; Giercksky KE
    Scand J Gastroenterol; 1985 Apr; 20(3):315-20. PubMed ID: 3890139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of plasma pancreatic polypeptide in achlorhydric patients after intravenous infusion of gastric inhibitory polypeptide.
    Jorde R; Burhol PG
    Digestion; 1983; 27(4):239-44. PubMed ID: 6360772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of gastric inhibitory polypeptide on human jejunal water and electrolyte transport.
    Helman CA; Barbezat GO
    Gastroenterology; 1977 Feb; 72(2):376-9. PubMed ID: 830596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gastric inhibitory polypeptide on dispersed pancreatic acinar cells from the guinea pig.
    Sjödin L; Conlon TP
    Acta Physiol Scand; 1984 Sep; 122(1):79-84. PubMed ID: 6209922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of insulin secretion by intravenous bolus injection and continuous infusion of gastric inhibitory polypeptide in patients with type 2 diabetes and healthy control subjects.
    Meier JJ; Gallwitz B; Kask B; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
    Diabetes; 2004 Dec; 53 Suppl 3():S220-4. PubMed ID: 15561915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of gastric inhibitory polypeptide (GIP) on the release of anterior pituitary hormones.
    Ottlecz A; Samson WK; McCann SM
    Peptides; 1985; 6(1):115-9. PubMed ID: 3991358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between the postprandial secretions of gastric inhibitory polypeptide (GIP) and pancreatic polypeptide (PP) in man.
    Jorde R; Burhol PG
    Mater Med Pol; 1987; 19(4):222-4. PubMed ID: 3454828
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of a gastric partitioning operation for morbid obesity on the secretion of gastric inhibitory polypeptide and pancreatic polypeptide.
    Amland PF; Jorde R; Kildebo S; Burhol PG; Giercksky KE
    Scand J Gastroenterol; 1984 Sep; 19(6):857-61. PubMed ID: 6393318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of gastric secretion by i.v. gastric inhibitory polypeptide (GIP) in man (author's transl)].
    Schafmayer A; Becker HD; Börger HW; Coelle EF; Arnold R; Creutzfeldt W
    Chir Forum Exp Klin Forsch; 1980; ():208-12. PubMed ID: 7389456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent increase in concentrations of gastric inhibitory polypeptide and pancreatic polypeptide after small amounts of glucose intraduodenally in man.
    Flaten O; Tronier B
    Scand J Gastroenterol; 1982 Aug; 17(5):677-80. PubMed ID: 7178831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The elimination rates of intact GIP as well as its primary metabolite, GIP 3-42, are similar in type 2 diabetic patients and healthy subjects.
    Vilsbøll T; Agersø H; Lauritsen T; Deacon CF; Aaboe K; Madsbad S; Krarup T; Holst JJ
    Regul Pept; 2006 Dec; 137(3):168-72. PubMed ID: 16934887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose dependent insulinotropic polypeptide (GIP) infused intravenously is insulinotropic in the fasting state in type 2 (non-insulin dependent) diabetes mellitus.
    Jones IR; Owens DR; Luzio S; Hayes TM
    Horm Metab Res; 1989 Jan; 21(1):23-6. PubMed ID: 2647605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of exogenous or endogenous gastric inhibitory polypeptide on the elimination rate of Intralipid in man.
    Jorde R; Pettersen JE; Burhol PG
    Acta Med Scand; 1984; 216(1):19-23. PubMed ID: 6485877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of amino acids and gastric inhibitory polypeptide on insulin release in dogs.
    Yovos JG; O'Dorisio TM; Pappas TN; Cataland S; Thomas FB; Mekhjian H; Carey LC
    Am J Physiol; 1982 Jan; 242(1):E53-8. PubMed ID: 7036753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal regulatory peptides during oxytocin infusion in post-term pregnancies.
    Holst N; Jenssen TG; Burhol PG; Jorde R
    Acta Physiol Scand; 1988 Jan; 132(1):23-7. PubMed ID: 2906209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of gastrointestinal peptides during E. coli endotoxinaemia.
    Revhaug A; Lygren I; Lundgren TI; Jorde R; Burhol PG; Giercksky KE
    Acta Chir Scand; 1984; 150(7):535-9. PubMed ID: 6151326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of peripheral administration of synthetic human glucose-dependent insulinotropic peptide (GIP) on energy expenditure and subjective appetite sensations in healthy normal weight subjects and obese patients with type 2 diabetes.
    Daousi C; Wilding JP; Aditya S; Durham BH; Cleator J; Pinkney JH; Ranganath LR
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):195-201. PubMed ID: 19178509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.